Drug resistance judgment standard test method of mycoplasma gallisepticum to danofloxacin
The invention discloses a drug resistance judgment standard test method of mycoplasma gallisepticum to danofloxacin, including the following steps: formulating a wild type critical value and a pharmacodynamic critical value of the danofloxacin to the mycoplasma gallisepticum, formulating a dosing sc...
Gespeichert in:
| Hauptverfasser: | , , , , , , , , , , , , , , , , , , , , , |
|---|---|
| Format: | Patent |
| Sprache: | chi ; eng |
| Schlagworte: | |
| Online-Zugang: | Volltext bestellen |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | |
|---|---|
| container_issue | |
| container_start_page | |
| container_title | |
| container_volume | |
| creator | FANG SHIWEI HUANG XIAO GUO JINLI CHENG GUYUE HU SISHUN PENG DAPENG WANG SHUGE GU YUFENG BI DINGREN DAI XINYU CHEN DONGMEI YUAN ZONGHUI XIE SHUYU TAO YANFEI YU GENGTAO WANG YULIAN PAN YUANHU WANG XU HUANG LINGLI QU WEI HAO HAIHONG HUANG ANXIONG |
| description | The invention discloses a drug resistance judgment standard test method of mycoplasma gallisepticum to danofloxacin, including the following steps: formulating a wild type critical value and a pharmacodynamic critical value of the danofloxacin to the mycoplasma gallisepticum, formulating a dosing scheme of the danofloxacin to the mycoplasma gallisepticum, formulating a clinical critical value of the danofloxacin to the mycoplasma gallisepticum, and obtaining a drug resistance judgment standard of the danofloxacin to the mycoplasma gallisepticum through a tree diagram which is made through a CLSI susceptibility breakpoint. With the adoption of the drug resistance judgment standard test method of mycoplasma gallisepticum to danofloxacin, the drug resistance judgment standard of the mycoplasma gallisepticum to the danofloxacin can be formulated; stable medication data support can be provided for scientific cultivation; clinical medication can be guided more scientifically; chronic respiratory diseases such as na |
| format | Patent |
| fullrecord | <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_CN110060784A</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>CN110060784A</sourcerecordid><originalsourceid>FETCH-epo_espacenet_CN110060784A3</originalsourceid><addsrcrecordid>eNqNyjEKAjEQQNFtLES9w3gAIYuitrIqVlY2VsuQzK6RJBMyE9Dbi-ABrD4P_rS5H0sdoZB4UUyW4FndGCkpfO2wOFAShUj6YAc8QHxbzgElIowYghfK6m2NoAwOEw-BX2h9mjeTAYPQ4tdZszyfbt1lRZl7koyWEmnfXdvWmK3Z7TeH9T_PB03PO4A</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>Drug resistance judgment standard test method of mycoplasma gallisepticum to danofloxacin</title><source>esp@cenet</source><creator>FANG SHIWEI ; HUANG XIAO ; GUO JINLI ; CHENG GUYUE ; HU SISHUN ; PENG DAPENG ; WANG SHUGE ; GU YUFENG ; BI DINGREN ; DAI XINYU ; CHEN DONGMEI ; YUAN ZONGHUI ; XIE SHUYU ; TAO YANFEI ; YU GENGTAO ; WANG YULIAN ; PAN YUANHU ; WANG XU ; HUANG LINGLI ; QU WEI ; HAO HAIHONG ; HUANG ANXIONG</creator><creatorcontrib>FANG SHIWEI ; HUANG XIAO ; GUO JINLI ; CHENG GUYUE ; HU SISHUN ; PENG DAPENG ; WANG SHUGE ; GU YUFENG ; BI DINGREN ; DAI XINYU ; CHEN DONGMEI ; YUAN ZONGHUI ; XIE SHUYU ; TAO YANFEI ; YU GENGTAO ; WANG YULIAN ; PAN YUANHU ; WANG XU ; HUANG LINGLI ; QU WEI ; HAO HAIHONG ; HUANG ANXIONG</creatorcontrib><description>The invention discloses a drug resistance judgment standard test method of mycoplasma gallisepticum to danofloxacin, including the following steps: formulating a wild type critical value and a pharmacodynamic critical value of the danofloxacin to the mycoplasma gallisepticum, formulating a dosing scheme of the danofloxacin to the mycoplasma gallisepticum, formulating a clinical critical value of the danofloxacin to the mycoplasma gallisepticum, and obtaining a drug resistance judgment standard of the danofloxacin to the mycoplasma gallisepticum through a tree diagram which is made through a CLSI susceptibility breakpoint. With the adoption of the drug resistance judgment standard test method of mycoplasma gallisepticum to danofloxacin, the drug resistance judgment standard of the mycoplasma gallisepticum to the danofloxacin can be formulated; stable medication data support can be provided for scientific cultivation; clinical medication can be guided more scientifically; chronic respiratory diseases such as na</description><language>chi ; eng</language><subject>HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATIONTECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING ORPROCESSING OF MEDICAL OR HEALTHCARE DATA ; INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTEDFOR SPECIFIC APPLICATION FIELDS ; PHYSICS</subject><creationdate>2019</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20190726&DB=EPODOC&CC=CN&NR=110060784A$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,780,885,25564,76419</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20190726&DB=EPODOC&CC=CN&NR=110060784A$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>FANG SHIWEI</creatorcontrib><creatorcontrib>HUANG XIAO</creatorcontrib><creatorcontrib>GUO JINLI</creatorcontrib><creatorcontrib>CHENG GUYUE</creatorcontrib><creatorcontrib>HU SISHUN</creatorcontrib><creatorcontrib>PENG DAPENG</creatorcontrib><creatorcontrib>WANG SHUGE</creatorcontrib><creatorcontrib>GU YUFENG</creatorcontrib><creatorcontrib>BI DINGREN</creatorcontrib><creatorcontrib>DAI XINYU</creatorcontrib><creatorcontrib>CHEN DONGMEI</creatorcontrib><creatorcontrib>YUAN ZONGHUI</creatorcontrib><creatorcontrib>XIE SHUYU</creatorcontrib><creatorcontrib>TAO YANFEI</creatorcontrib><creatorcontrib>YU GENGTAO</creatorcontrib><creatorcontrib>WANG YULIAN</creatorcontrib><creatorcontrib>PAN YUANHU</creatorcontrib><creatorcontrib>WANG XU</creatorcontrib><creatorcontrib>HUANG LINGLI</creatorcontrib><creatorcontrib>QU WEI</creatorcontrib><creatorcontrib>HAO HAIHONG</creatorcontrib><creatorcontrib>HUANG ANXIONG</creatorcontrib><title>Drug resistance judgment standard test method of mycoplasma gallisepticum to danofloxacin</title><description>The invention discloses a drug resistance judgment standard test method of mycoplasma gallisepticum to danofloxacin, including the following steps: formulating a wild type critical value and a pharmacodynamic critical value of the danofloxacin to the mycoplasma gallisepticum, formulating a dosing scheme of the danofloxacin to the mycoplasma gallisepticum, formulating a clinical critical value of the danofloxacin to the mycoplasma gallisepticum, and obtaining a drug resistance judgment standard of the danofloxacin to the mycoplasma gallisepticum through a tree diagram which is made through a CLSI susceptibility breakpoint. With the adoption of the drug resistance judgment standard test method of mycoplasma gallisepticum to danofloxacin, the drug resistance judgment standard of the mycoplasma gallisepticum to the danofloxacin can be formulated; stable medication data support can be provided for scientific cultivation; clinical medication can be guided more scientifically; chronic respiratory diseases such as na</description><subject>HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATIONTECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING ORPROCESSING OF MEDICAL OR HEALTHCARE DATA</subject><subject>INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTEDFOR SPECIFIC APPLICATION FIELDS</subject><subject>PHYSICS</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2019</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNqNyjEKAjEQQNFtLES9w3gAIYuitrIqVlY2VsuQzK6RJBMyE9Dbi-ABrD4P_rS5H0sdoZB4UUyW4FndGCkpfO2wOFAShUj6YAc8QHxbzgElIowYghfK6m2NoAwOEw-BX2h9mjeTAYPQ4tdZszyfbt1lRZl7koyWEmnfXdvWmK3Z7TeH9T_PB03PO4A</recordid><startdate>20190726</startdate><enddate>20190726</enddate><creator>FANG SHIWEI</creator><creator>HUANG XIAO</creator><creator>GUO JINLI</creator><creator>CHENG GUYUE</creator><creator>HU SISHUN</creator><creator>PENG DAPENG</creator><creator>WANG SHUGE</creator><creator>GU YUFENG</creator><creator>BI DINGREN</creator><creator>DAI XINYU</creator><creator>CHEN DONGMEI</creator><creator>YUAN ZONGHUI</creator><creator>XIE SHUYU</creator><creator>TAO YANFEI</creator><creator>YU GENGTAO</creator><creator>WANG YULIAN</creator><creator>PAN YUANHU</creator><creator>WANG XU</creator><creator>HUANG LINGLI</creator><creator>QU WEI</creator><creator>HAO HAIHONG</creator><creator>HUANG ANXIONG</creator><scope>EVB</scope></search><sort><creationdate>20190726</creationdate><title>Drug resistance judgment standard test method of mycoplasma gallisepticum to danofloxacin</title><author>FANG SHIWEI ; HUANG XIAO ; GUO JINLI ; CHENG GUYUE ; HU SISHUN ; PENG DAPENG ; WANG SHUGE ; GU YUFENG ; BI DINGREN ; DAI XINYU ; CHEN DONGMEI ; YUAN ZONGHUI ; XIE SHUYU ; TAO YANFEI ; YU GENGTAO ; WANG YULIAN ; PAN YUANHU ; WANG XU ; HUANG LINGLI ; QU WEI ; HAO HAIHONG ; HUANG ANXIONG</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_CN110060784A3</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>chi ; eng</language><creationdate>2019</creationdate><topic>HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATIONTECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING ORPROCESSING OF MEDICAL OR HEALTHCARE DATA</topic><topic>INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTEDFOR SPECIFIC APPLICATION FIELDS</topic><topic>PHYSICS</topic><toplevel>online_resources</toplevel><creatorcontrib>FANG SHIWEI</creatorcontrib><creatorcontrib>HUANG XIAO</creatorcontrib><creatorcontrib>GUO JINLI</creatorcontrib><creatorcontrib>CHENG GUYUE</creatorcontrib><creatorcontrib>HU SISHUN</creatorcontrib><creatorcontrib>PENG DAPENG</creatorcontrib><creatorcontrib>WANG SHUGE</creatorcontrib><creatorcontrib>GU YUFENG</creatorcontrib><creatorcontrib>BI DINGREN</creatorcontrib><creatorcontrib>DAI XINYU</creatorcontrib><creatorcontrib>CHEN DONGMEI</creatorcontrib><creatorcontrib>YUAN ZONGHUI</creatorcontrib><creatorcontrib>XIE SHUYU</creatorcontrib><creatorcontrib>TAO YANFEI</creatorcontrib><creatorcontrib>YU GENGTAO</creatorcontrib><creatorcontrib>WANG YULIAN</creatorcontrib><creatorcontrib>PAN YUANHU</creatorcontrib><creatorcontrib>WANG XU</creatorcontrib><creatorcontrib>HUANG LINGLI</creatorcontrib><creatorcontrib>QU WEI</creatorcontrib><creatorcontrib>HAO HAIHONG</creatorcontrib><creatorcontrib>HUANG ANXIONG</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>FANG SHIWEI</au><au>HUANG XIAO</au><au>GUO JINLI</au><au>CHENG GUYUE</au><au>HU SISHUN</au><au>PENG DAPENG</au><au>WANG SHUGE</au><au>GU YUFENG</au><au>BI DINGREN</au><au>DAI XINYU</au><au>CHEN DONGMEI</au><au>YUAN ZONGHUI</au><au>XIE SHUYU</au><au>TAO YANFEI</au><au>YU GENGTAO</au><au>WANG YULIAN</au><au>PAN YUANHU</au><au>WANG XU</au><au>HUANG LINGLI</au><au>QU WEI</au><au>HAO HAIHONG</au><au>HUANG ANXIONG</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>Drug resistance judgment standard test method of mycoplasma gallisepticum to danofloxacin</title><date>2019-07-26</date><risdate>2019</risdate><abstract>The invention discloses a drug resistance judgment standard test method of mycoplasma gallisepticum to danofloxacin, including the following steps: formulating a wild type critical value and a pharmacodynamic critical value of the danofloxacin to the mycoplasma gallisepticum, formulating a dosing scheme of the danofloxacin to the mycoplasma gallisepticum, formulating a clinical critical value of the danofloxacin to the mycoplasma gallisepticum, and obtaining a drug resistance judgment standard of the danofloxacin to the mycoplasma gallisepticum through a tree diagram which is made through a CLSI susceptibility breakpoint. With the adoption of the drug resistance judgment standard test method of mycoplasma gallisepticum to danofloxacin, the drug resistance judgment standard of the mycoplasma gallisepticum to the danofloxacin can be formulated; stable medication data support can be provided for scientific cultivation; clinical medication can be guided more scientifically; chronic respiratory diseases such as na</abstract><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext_linktorsrc |
| identifier | |
| ispartof | |
| issn | |
| language | chi ; eng |
| recordid | cdi_epo_espacenet_CN110060784A |
| source | esp@cenet |
| subjects | HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATIONTECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING ORPROCESSING OF MEDICAL OR HEALTHCARE DATA INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTEDFOR SPECIFIC APPLICATION FIELDS PHYSICS |
| title | Drug resistance judgment standard test method of mycoplasma gallisepticum to danofloxacin |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-07T16%3A03%3A19IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=FANG%20SHIWEI&rft.date=2019-07-26&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3ECN110060784A%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true |